Open access · OA
via OpenAlex
Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1: Rapid Communication
Lili Feng, Shizhong Chen, Gabriela E. Garcia, Yiyang Xia, Mike A. Siani, Paulo Botti, Curtis B. Wilson, Jeffrey K. Harrison, Kevin B. Bacon
Kidney International · 1999 · ▲ 202 citations
Abstract
This 1999 study in Kidney International examines the role of CX3CR1 immunoneutralization in the prevention of crescentic glomerulonephritis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1046/j.1523-1755.1999.00604.x
- Canonical
- link ↗
- Fetched
- 2026-07-10 MST
Cite this
APA
Feng, L., Chen, S., Garcia, G.E., Xia, Y., Siani, M.A., Botti, P., Wilson, C.B., Harrison, J.K., & Bacon, K.B. (1999). Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1: Rapid Communication. <em>Kidney International</em>. https://doi.org/10.1046/j.1523-1755.1999.00604.x
Vancouver
Feng L, Chen S, Garcia GE, Xia Y, Siani MA, Botti P, et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1: Rapid Communication. Kidney International. 1999. doi:10.1046/j.1523-1755.1999.00604.x.
BibTeX
@article{lili1999Preven,
title = {Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1: Rapid Communication},
author = {Lili Feng and Shizhong Chen and Gabriela E. Garcia and Yiyang Xia and Mike A. Siani and Paulo Botti and Curtis B. Wilson and Jeffrey K. Harrison and Kevin B. Bacon},
journal = {Kidney International},
year = {1999},
doi = {10.1046/j.1523-1755.1999.00604.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Metabolism 2012
Open access · OA
TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
Cell 2006
Open access · OA
SMK-1, an Essential Regulator of DAF-16-Mediated Longevity
Aging 2020
Open access · OA
Rapamycin for aging stem cells
Experimental Gerontology 2023
Open access · CC-BY
Rapamycin, the only drug that has been consistently demonstrated to increase mammalian longevity. An update
Nature 2010
Preprint · OA
A new DAF-16 isoform regulates longevity
Aging Cell 2010
Citation only